Stockscreener 앱 받기
0.2338
3.00%
0.0068
전일 마감가:
$0.227
열려 있는:
$0.242
하루 거래량:
143.16K
Relative Volume:
0.98
시가총액:
$4.01M
수익:
$9.15M
순이익/손실:
$-16.18M
주가수익비율:
-0.1328
EPS:
-1.76
순현금흐름:
$-15.92M
1주 성능:
-0.93%
1개월 성능:
-52.30%
6개월 성능:
-78.14%
1년 성능:
-94.98%
1일 변동 폭
$0.22
$0.2464
1주일 범위
$0.22
$0.27
52주 변동 폭
$0.205
$4.72
Aspira Womens Health Inc Stock (AWH) Company Profile
명칭
Aspira Womens Health Inc
전화
512-519-0400
주소
12117 BEE CAVES ROAD BUILDING THREE, AUSTIN
AWH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AWH
Aspira Womens Health Inc
|
0.24 | 4.01M | 9.15M | -16.18M | -15.92M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
537.42 | 205.72B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
212.06 | 149.54B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
136.41 | 39.02B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
458.91 | 37.08B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
195.09 | 34.17B | 15.41B | 1.37B | 2.11B | 7.50 |
Aspira Womens Health Inc Stock (AWH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-01-12 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-29 | 개시 | Truist | Buy |
| 2021-01-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-30 | 개시 | William Blair | Outperform |
Aspira Womens Health Inc 주식(AWH)의 최신 뉴스
Aspira Women's Health regains Nasdaq compliance - MSN
Aspira Women’s Health withdraws public offering plan By Investing.com - Investing.com Nigeria
Aspira Women's Health withdraws public offering plan - MSN
Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement - ACCESS Newswire
Major Strategic Shift: Aspira Women's Health Halts Public Offering Plans - StockTitan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
SRG Promotes Melissa Dillon to Vice President of Memory Care - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Aspira Women's Health Announces Executive Changes - MSN
Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors - ACCESS Newswire
Strategic Power Move: Aspira Women's Health Taps Diagnostics Veteran for Board Leadership - StockTitan
Aspira Women's Health Inc. Announces Board Changes -February 10, 2025 at 05:01 pm EST - Marketscreener.com
Aspira Women's Health Announces Executive Changes By Investing.com - Investing.com South Africa
Aspira Women’s Health Announces Leadership Changes in 2025 - TipRanks
New CEO to take over Alta Care Group - MSN
Two more Southwest Airlines board members step down, completing Elliott makeover - MSN
Arcus Biosciences appoints new board member - MSN
BSA Health System launches new maternal care group - MSN
Ratios in Focus: Analyzing Aspira Women’s Health Inc (AWH)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Ratio Analysis: Unpacking Gap, Inc (GAP)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Deeper Dive: Understanding Redwire Corporation (RDW) Through its Various Ratios - The Dwinnex
Aspira Women's Health appoints new CEO and VP of Finance - MSN
Aspira Women's Health Inc. Announces Chief Executive Officer Changes -January 31, 2025 at 06:15 am EST - Marketscreener.com
Aspira Women’s Health appoints new CEO and VP of Finance By Investing.com - Investing.com Nigeria
RBG Holdings announces departure of Non-Executive Director - MSN
SEC Form FWP filed by Aspira Women's Health Inc. - Quantisnow
Aspira Women’s Health Announces Key Leadership Changes - TipRanks
Aspira Women's Health appoints new CEO and VP of Finance By Investing.com - Investing.com Canada
AWH Stock Plummets to 52-Week Low of $0.38 Amid Market Struggles - Investing.com UK
Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - ACCESS Newswire
$31.46 Billion Women's Health Diagnostics Industry Outlook, - GlobeNewswire
Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, a - Defense World
New Concept Energy (NYSE:GBR) Coverage Initiated at StockNews.com - Defense World
Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com - Defense World
Aspira Women’s Health Appoints Mike Buhle as SVP of Commercial Operations - citybiz
Aspira Women's Health Inc. Appoints Mike Buhle as SVP of Commercial Operations - Marketscreener.com
Aspira Women's Health Strengthens Leadership Team with Key Commercial and Financial Appointments - StockTitan
Aspira Women's Health CFO resigns, CEO assumes duties - Investing.com
Aspira Women’s Health CFO Resignation and Leadership Update - TipRanks
AWH Stock Surges Over 5% Amid Mixed Analyst Ratings - GuruFocus.com
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World
Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis - CTPost
Aspira Women’s Health (NASDAQ:AWH) Earns Hold Rating from Analysts at StockNews.com - Defense World
Organon & Co. (NYSE: OGN) Reduces Board Size Following Resignation of Director - Defense World
Aspira Women's Health's SWOT analysis: stock outlook amid diagnostic growth - Investing.com India
Aspira Women's Health CEO steps down, interim appointed By Investing.com - Investing.com Canada
Aspira Women’s Health CEO Transition and Leadership Change - TipRanks
AWHAspira Women's Health Inc. Latest Stock News & Market Updates - StockTitan
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer - citybiz
Aspira Women’s Health Appoints Dr. Sandra Milligan as Interim CEO - citybiz
Aspira Womens Health Inc (AWH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aspira Womens Health Inc 주식 (AWH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Fralick Celeste Rachelle | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,000 |
0 |
50,665 |
| Parnell Winfred | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,157 |
0 |
60,897 |
| Cavanaugh Stefanie L. | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,937 |
0 |
66,851 |
| Ragard John Phillip | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
4,844 |
0 |
125,047 |
| Milligan Sandra | Interim CEO & President |
Dec 31 '24 |
Option Exercise |
0.00 |
20,000 |
0 |
20,000 |
| Vos Ellen O'Connor | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,312 |
0 |
63,364 |
| Vos Ellen O'Connor | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,313 |
0 |
58,052 |
| Cavanaugh Stefanie L. | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,938 |
0 |
60,914 |
| Parnell Winfred | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,156 |
0 |
55,740 |
| Herchuk Jannie Prestridge | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
8,438 |
0 |
57,190 |
0.05%
0.38%
자본화:
|
볼륨(24시간):